Skip to Main Content


Ross Merkin, MD

Clinical Fellow

Contact Information

Ross Merkin, MD

Research Summary

My research focuses on toxicities that occur as a result of immunotherapy. Immune checkpoint inhibitors leverage the immune system to kill cancer cells that have learned to evade the immune system, and have led to dramatic improvements in patient survival and quality of life in some cancers. Side effects from these medications range from mild to severe and may require treatment with immunosuppressive medications such as steroids. By gaining a better understanding of how these toxicities occur we can learn how to treat them better and allow for optimal cancer treatment with immune checkpoint inhibitors.

Research Interests

Immunoproteins; Skin Neoplasms; Thoracic Neoplasms; Biomarkers

Selected Publications